Great f.y.i. Get hooked here!
Local, national & international business news and events.
Company to Add Accomplished Leaders with Diverse Experience to the Board WALNUT CREEK, Calif.–(BUSINESS WIRE)–Central Garden & Pet Company (NASDAQ: CENT, CENTA) (“Central”), a market leader in the garden and pet industries, today announced that it has nominated two new independent directors,
The agreement means the companies will supply a total of 200 million doses, enough to vaccinate 100 million Americans. — NYT: Top Stories
They also discuss the slippery slope from guns to sugary cereals. — NYT: Top Stories
PRINCETON, N.J. — (BUSINESS WIRE) — $BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today announced an update on CheckMate -548, a Phase 3 trial evaluating the addition of Opdivo (nivolumab) to the current standard of care (temozolomide and radiation therapy) versus placebo plus
The welter of providers, layers of state and local regulation, and lack of information about costs made lawmakers hesitant to take up the issue. But that may change. — NYT: Top Stories
“Saint Chuck” Will Start the Season of Giving by Delivering More than $30 Million in Presents to FanDuel Customers NEW YORK–(BUSINESS WIRE)–Today, FanDuel Group announced an exclusive content deal with Sports Emmy Award-winning analyst and Naismith Memorial Basketball Hall of Famer Charles
SAN DIEGO — (BUSINESS WIRE) — EDF Renewables North America today announced the Space City Solar Project is progressing with critical development milestones having signed the first tranche of 55 megawatts (MWac) / 73 MWdc to BASF through a Power Purchase Agreement.
Actor Danny Trejo partnered with the Everest Foundation to help feed frontline workers and their families in East Los Angeles during a drive-up food giveaway at the Civic Center. — FOX News
Legend Biotech also achieves fifth milestone payment under its collaboration agreement with Janssen in clinical development of cilta-cel SOMERSET, N.J.–(BUSINESS WIRE)–#LegendBiotech–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies